ReviewFrontiers in immunology2021

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?

Sarah Cormican et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.